Literature DB >> 2628166

An ordered pathway of assembly of components required for polyadenylation site recognition and processing.

G M Gilmartin1, J R Nevins.   

Abstract

Four HeLa cell nuclear factors that are required for specific pre-mRNA cleavage and polyadenylation have been extensively purified, thereby permitting an investigation of the role of each in the 3' processing reaction. Two factors, termed PF1 and PF2, are required for specific polyadenylation of the cleaved RNA. PF1 is a poly(A) polymerase, and PF2 is a factor that confers AAUAAA specificity to the reaction. Both of these factors, along with two additional factors termed CF1 and CF2, are required for the endonucleolytic cleavage of the pre-mRNA. The ability of each of these factors to form specific complexes with the pre-mRNA was assayed using native gel electrophoresis. Two distinct complexes were detected. PF2 forms an initial complex with the pre-RNA, dependent on the AAUAAA sequence element but independent of specific downstream sequences. Formation of the PF2-RNA complex permits the subsequent interaction of CF1 and the formation of a second, larger complex. CF1 binding requires the downstream sequence element in addition to PF2 binding. Whereas the PF2-RNA complex is unstable and dissociates rapidly, the ternary complex formed by CF1, PF2, and RNA is stable. Thus, the interaction of CF1, dependent on the downstream sequence element, can be viewed as a commitment of the poly(A) site for processing. On the addition of the poly(A) polymerase (PF1) and factor CF2, the pre-mRNA is specifically cleaved at the poly(A) site.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2628166     DOI: 10.1101/gad.3.12b.2180

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  89 in total

1.  Utilization of splicing elements and polyadenylation signal elements in the coupling of polyadenylation and last-intron removal.

Authors:  C Cooke; H Hans; J C Alwine
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Recruitment of a basal polyadenylation factor by the upstream sequence element of the human lamin B2 polyadenylation signal.

Authors:  S Brackenridge; N J Proudfoot
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Crystal structure of mammalian poly(A) polymerase in complex with an analog of ATP.

Authors:  G Martin; W Keller; S Doublié
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

4.  Regulation of nuclear poly(A) addition controls the expression of immunoglobulin M secretory mRNA.

Authors:  C Phillips; S Jung; S I Gunderson
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

Review 5.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

6.  Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice.

Authors:  S Perfumo; L Amicone; S Colloca; M Giorgio; L Pozzi; M Tripodi
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

7.  Regulated adenovirus mRNA 3'-end formation in a coupled in vitro transcription-processing system.

Authors:  S I Wilson-Gunn; J E Kilpatrick; M J Imperiale
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

8.  Separation of factors required for cleavage and polyadenylation of yeast pre-mRNA.

Authors:  J Chen; C Moore
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

9.  Balanced efficiencies of splicing and cleavage-polyadenylation are required for mu-s and mu-m mRNA regulation.

Authors:  M L Peterson
Journal:  Gene Expr       Date:  1992

10.  Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions.

Authors:  P A Furth; W T Choe; J H Rex; J C Byrne; C C Baker
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.